Canada markets closed

OncoCyte Corporation (OCX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9700+0.2500 (+6.72%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.7200
Open3.7200
Bid3.7800 x 1200
Ask3.9900 x 800
Day's Range3.6600 - 4.0800
52 Week Range1.2000 - 6.5700
Volume2,214,390
Avg. Volume650,165
Market Cap363.58M
Beta (5Y Monthly)1.84
PE Ratio (TTM)N/A
EPS (TTM)-0.3590
Earnings DateNov. 10, 2021 - Nov. 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
  • GlobeNewswire

    Modern Healthcare Recognizes Oncocyte as One of the 2021 Best Places to Work in Healthcare

    CHICAGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, announced today that Modern Healthcare had selected it as one of the 2021 Best Places to Work in Healthcare. The complete list of this year’s winners, in alphabetical order, is available at ModernHealthcare.com/bes

  • GlobeNewswire

    Oncocyte to Present New Data on DetermaIO™ from NeoTRIPaPDL1 Trial in Oral Presentation from Late-Breaking Abstract at ESMO 2021

    Data represents first evaluation of DetermaIO in gold-standard randomized clinical trial in triple negative breast cancerIRVINE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, announced today that it will present new data from ongoing clinical research evaluatin

  • GlobeNewswire

    Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference

    IRVINE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that management will participate in one-on-one and group investor meetings at the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference. Conference Details: 5th Annual Lake Stre